OBERWEIS ASSET MANAGEMENT INC/
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 937886
LISLE, IL
Position in INDV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,970,083
+$12,054,055 QoQ
Shares Held
779,188
+19.2% QoQ
Ownership
0.660%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#35
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OBERWEIS ASSET MANAGEMENT INC/ holds $140,674,369 across 6 Drug Manufacturers - Specialty & Generic names. INDV ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
406,400 | $32,402,272 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
779,188 | $31,970,083 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
413,034 | $26,413,524 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
265,306 | $21,962,030 | |
| 5 | ETON |
Eton Pharmaceuticals, Inc.
|
501,600 | $18,157,920 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
311,100 | $9,768,540 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,970,083 | 779,188 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,916,028 | 653,413 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||